Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Functional lesional neurosurgery for tremor.

Thalamotomy with focused ultrasound as a therapy for essential tremor.

    • Neurology
    • RX
    • Studies
    • Surgery
  • 3 minute read

Purpose: Does thalamotomy using MR-guided focused ultrasound (MRgFUS) significantly improve tremor in patients with previously refractory essential tremor (ET) compared with sham treatment, and does the side effect profile justify this stereotactic therapeutic approach?

Background: From non-controlled studies, thalamotomy by MRgFUS leads to improvement of tremor in patients suffering from ET. Controlled studies are not yet available for this comparatively new therapeutic procedure.

PATIENTS AND METHODS: This multicenter, double-blind, randomized study included patients with moderate to severe ET who responded to at least two drug treatment trials including. propranolol or primidone had not responded. Patients were randomized in a 3:1 ratio, assigned to stereotactic thalamotomy by MRgFUS or sham intervention, which proceeded in a manner analogous to thalamotomy without delivering acoustic energy to the brain during sonication periods. Only the treatment team knew to which group the patients were assigned; patients and investigators were blinded. The anatomical target was the nucleus ventralis intermedius of the thalamus (Vim), a target also used in deep brain stimulation (DBS) in the treatment of tremor syndromes. Tremor severity was assessed with the Clinical Rating Scale for Tremor (CRST), and quality of life was assessed with the Quality of Life in Essential Tremor (QUEST) questionnaire. The study was performed at baseline and at 1, 3, 6 and 12 months. The tremor examination was videotaped and assessed by an independent group of neurologists who were unaware of the treatment allocation. After 3 months, patients in the sham treatment group had the option to switch to the treatment group.

Results: 76 patients were included in the analysis (56 MRgFUS thalamotomy, 20 sham treatment). The CRST is a point scale ranging from 0-32, with higher scores indicating more clinical involvement. Hand tremor contralateral to the cerebrally treated side improved more markedly in the MRgFUS thalamotomy group (from 18.1 to 9.6 points at 3 months) than in the sham treatment group (from 16.0 to 15.8 points). This improvement in the thalamotomy group remained stable over the 12-month period. In the thalamotomy group, quality of life improved analogously to the clinical tremor reduction compared with the sham-treated group. Side effects were gait disturbances in 36% of cases in the thalamotomy group and paresthesias and numbness in 38% of cases, which persisted for 12 months in 9 and 14% of patients, respectively.

Authors’ conclusions: The results show that the described improvement is due to the treatment and it is not a placebo effect.

Comment: The present study is the long-awaited controlled trial confirming the promising results of smaller uncontrolled case series. Of particular importance is that the use of a sham-treated comparison group demonstrated that this was not a placebo effect. It should be emphasized that these were severely affected patients who could not be adequately treated with the usual conservative therapies available, including primidone and propranolol. The crucial question for affected patients remains whether the disease-related reduction in quality of life justifies the risks of stereotactic therapy. However, this question is analogous to the use of DBS, the efficacy of which has been demonstrated in several controlled studies and is considered the gold standard for surgical treatment of ET. Accordingly, another control group of DBS-treated patients would have been desirable to compare the advantages and disadvantages of the two invasive procedures. According to the study presented here, we know that in the treatment of ET, both therapeutic methods are effective.

 

InFo NEUROLOGY & PSYCHIATRY 2016; 14(6): 42.

Autoren
  • Dr. med. Stefan Hägele-Link
Publikation
  • InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
  • ET
  • Neurosurgery
  • Tremor
Previous Article
  • Chronic Fatigue Syndrome

Hope through rituximab?

  • Neurology
  • Pharmacology and toxicology
  • RX
  • Studies
View Post
Next Article
  • Stroke patients should be treated in the stroke unit

Stroke unit or stroke team?

  • Neurology
  • RX
  • Studies
View Post
You May Also Like
View Post
  • 6 min
  • Chronic musculoskeletal pain

How can the use of analgesics be optimized in multimodal therapy?

    • Congress Reports
    • General Internal Medicine
    • Orthopedics
    • Pharmacology and toxicology
    • Physical medicine and rehabilitation
    • Rheumatology
    • RX
    • Studies
View Post
  • 6 min
  • Interview with Prof. Thomas Kündig (USZ)

“If we control itching and eczema, a normal life is possible again”

    • Allergology and clinical immunology
    • Dermatology and venereology
    • Interviews
    • Partner Content
    • RX
View Post
  • 3 min
  • From symptom to diagnosis

Abdominal pain – groin pain: internal causes

    • Cases
    • Education
    • Gynecology
    • Radiology
    • RX
    • Surgery
    • Urology
View Post
  • 2 min
  • Chronic pain

Nano-ECS modulator Adezunap improves therapy success

    • Congress Reports
    • General Internal Medicine
    • Pharmaceutical medicine
    • Pharmacology and toxicology
    • Phytotherapy
    • Rheumatology
    • RX
    • Studies
View Post
  • 8 min
  • Psoriasis and PsA

Biologics, oral peptide and trivalent nanobody – current results and trends

    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • Rheumatology
    • RX
    • Studies
View Post
  • 5 min
  • Cancer in Europe: facts and analysis

New Health Policy Report published

    • General Internal Medicine
    • Oncology
    • Practice Management
    • Prevention and health care
    • RX
    • Studies
View Post
  • 4 min
  • Gastrointestinal complaints

PPI regulation under the microscope

    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Pharmacology and toxicology
    • RX
    • Studies
View Post
  • 6 min
  • Wound management: clinical diagnostics

Assessing the risk of infection – from the ABCDE to the TILI score

    • Congress Reports
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Geriatrics
    • Infectiology
    • Interviews
    • Physical medicine and rehabilitation
    • Prevention and health care
    • RX
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
Top CME content
  • 1
    How combination therapies lead to better treatment results
  • 2
    Interplay between cancer and mental illness
  • 3
    PH and lung diseases
  • 4
    Treatment of comorbidities in older people
  • 5
    Multidisciplinary teams in oncology

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.